Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2018

01-01-2018 | Images

Griscelli Syndrome with Fibronodular Sclerodermatous Chronic Graft Versus Host Disease

Author: Rahul Naithani

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2018

Login to get access

Excerpt

A 4-year male presented to us with Griscelli syndrome with Rab 27A mutation. His elder sibling died of same illness at 8 years’ age. He received allogeneic matched sibling donor peripheral blood stem cell transplant (PBSCT) from his sister in October 2015. He received conditioning regime with busulfan, cyclophosphamide and horse antithymocyte globulin [1]. Tacrolimus and methotrexate were used as graft versus host disease (GVHD) prophylaxis. He engrafted on day 13 of PBSCT. …
Literature
1.
Schuster F, Stachel DK, Schmid I, Baumeister FA, Graubner UB, Weiss M et al (2001) Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant 28(4):409–412CrossRefPubMed
2.
Şanlı H, Akay BN, Soydan E, Koçyiğit P, Arat M, İlhan O (2010) Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation. Turk J Haematol 27(2):91–98CrossRefPubMed
3.
Villarreal CD, Alanis JC, Pérez JC, Candiani JO (2016) Cutaneous graft-versus-host disease after hematopoietic stem cell transplant—a review. An Bras Dermatol 91(3):336–343CrossRefPubMedPubMedCentral
Metadata
Title
Griscelli Syndrome with Fibronodular Sclerodermatous Chronic Graft Versus Host Disease
Author
Rahul Naithani
Publication date
01-01-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0817-9

Other articles of this Issue 1/2018

Indian Journal of Hematology and Blood Transfusion 1/2018 Go to the issue

Original Article

Evaluating New Markers for Minimal Residual Disease Analysis by Flow Cytometry in Precursor B Lymphoblastic Leukemia

Images

Stodtmeister Cells (Polymorphs with Pelger-Huët Anomaly) Showing “Faggots” in Mixed Phenotypic Acute Leukemia (T/Myeloid)

Original Article

Comparative Study of Clinico-hematological Features, Molecular Spectrum and Response to Imatinib in Chronic Myelogenous Leukemia Patients: Pediatric and Adolescent Versus Adults

Original Article

A Study of Preoperative Autologous Blood Donation Timing

Correspondence

Florid Plasmacytosis in Angioimmunoblastic T Cell Lymphoma: A Diagnostic Conundrum

Original Article

Cost of Treatment of Multiple Myeloma in a Public Sector Tertiary Care Hospital of North India
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits